https://doi.org/10.4081/hmr.v2i7.426

The effect of adding rituximab to high dose chemotherapy

Vol. 2 No. 7: New Insights in Hematology, Venice (Italy), May 14-17, 2006
Published: June 8, 2009
Abstract Views: 223
PDF: 391
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

U Vitolo
support@pagepress.org
A Chiappella
G Rossi
E Angelucci
M Liberati
E Liberati
High-dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT) has been proved to be an effective salvage treatment in chemo-sensitive relapsed patients for both aggressive and indolent lymphomas. Since that, many investigators have extended this approach as part of the initial therapy of patients with aggressive lymphomas, especially those considered at poor prognosis, with conflicting results in randomized studies. Indeed a recent meta-analyses of up to 11 randomized trials in aggressive lymphomas, showed a similar OS in patients receiving first-line HDC + ASCT or standard chemotherapy.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Vitolo, U., Chiappella, A., Rossi, G., Angelucci, E., Liberati, M., & Liberati, E. (2009). The effect of adding rituximab to high dose chemotherapy. Hematology Meeting Reports (formerly Haematologica Reports), 2(7). https://doi.org/10.4081/hmr.v2i7.426
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).